Change in Metabolic Syndrome of the Primary Care-Based National Lifestyle Intervention Program: An Observation Cohort Study

Author(s)

Tan ECH1, Hsiao FYS2, Wu CC3, Wei SL3, Wu CY3, Jou YY3, Ms HL3, Hsueh HC3, Yang YH1
1Department of Health Services Administration, China Medical University, Taichung, TXG, Taiwan, 2Graduate Institute of Clinical Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan, 3Health Promotion Administration, Ministry of Health and Welfare, Taipei, Taiwan

OBJECTIVES: Metabolic syndrome (MetS) encompasses a set of risk factors for cardiovascular disease, diabetes, and all-cause mortality and becomes a common health issue that imposes a significant burden on healthcare systems. The primary components of MetS include obesity (particularly central adiposity), hypertension, hypertriglyceridemia, low high-density lipoprotein (HDL) cholesterol, and hyperglycemia. Early lifestyle intervention and health guidance are crucial for preventing the onset of chronic diseases. Enhancing self-management awareness in patients with MetS can prevent related chronic diseases and complications, reduce healthcare utilization, and lessen societal burdens, thereby achieving the goal of health investment.

METHODS: In July 2022, the Health Promotion Administration and the National Health Insurance Administration in Taiwan launched a national lifestyle intervention program targeting metabolic syndrome. Individuals aged 20 to 64 years with MetS or pre-diabetes are eligible for the program, which includes counseling and educational sessions on lifestyle changes (such as physical activity, nutrition, the ‘722 protocol’ for home blood pressure monitoring, and smoking cessation) conducted by community clinics. The program provides financial incentives for healthcare providers to enhance patients’ health literacy, offer follow-up every three months, and conduct annual examinations for metabolic syndrome.

RESULTS: By June 1, 2024, a total of 194,221 patients had joined the program, and 39,334 of them, having received at least three follow-up visits, were included in the analysis. The mean age of the patients was 52.3±8.7 years, and the majority were male (54.2%). Most participants (88.8%) met at least three MetS criteria. There was significant improvement in HDL levels (52.0%) and hypertriglyceridemia (49.1%). Participants showed a marked reduction in the number of MetS criteria they met (34.4%), and 14.6% of them achieved remission from MetS.

CONCLUSIONS: The national community clinic-based lifestyle intervention program, which includes counseling on diet and exercise and health literacy education, resulted in significant improvements in MetS and demonstrated phased achievements.

Conference/Value in Health Info

2024-11, ISPOR Europe 2024, Barcelona, Spain

Value in Health, Volume 27, Issue 12, S2 (December 2024)

Code

HSD121

Topic

Clinical Outcomes, Epidemiology & Public Health, Patient-Centered Research

Topic Subcategory

Clinical Outcomes Assessment, Patient Behavior and Incentives, Public Health

Disease

Diabetes/Endocrine/Metabolic Disorders (including obesity), No Additional Disease & Conditions/Specialized Treatment Areas

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×